RNS
AERI

Robert N. Shapiro’s Aerie Pharmaceuticals AERI Stock Holding History

Robert N. Shapiro’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$49K Hold
1,676
– – 0.01% 461
2014
Q3 		$35K Buy
1,676
+788
+89% +$15.5K 0.01% 541
2014
Q2 		$22K Hold
888
– – ﹤0.01% 580
2014
Q1 		$19K Buy
+888
New +$17.9K ﹤0.01% 585

Other funds holding AERI

CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Robert N. Shapiro's AERI Position: Q4 2014 in Review

Robert N. Shapiro held its Aerie Pharmaceuticals (AERI) position steady in Q4 2014 at 1,676 shares worth $49K. The position accounts for 0.01% of the portfolio, ranked #461.

Robert N. Shapiro first reported a position in AERI in Q1 2014 and has held it in 4 quarters since. 98 funds tracked by Wall St. Rank hold AERI as of Q4 2014.

  • Robert N. Shapiro held 1,676 shares of Aerie Pharmaceuticals worth $49K as of Q4 2014.
  • Robert N. Shapiro left its Aerie Pharmaceuticals share count unchanged in Q4 2014.
  • Aerie Pharmaceuticals made up 0.01% of Robert N. Shapiro's portfolio in Q4 2014, its #461 holding.
  • Robert N. Shapiro first reported a position in Aerie Pharmaceuticals in Q1 2014 and has held it in 4 quarters since.
  • 98 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2014.

Based on Robert N. Shapiro's 13F filing for Q4 2014, filed 19 Feb 2015.